CPT 87637: Multiplex Molecular Test for SARS–CoV‑2, Influenza A/B, RSV
CPT code 87637 describes a laboratory multiplex amplified nucleic acid probe test that detects and differentiates SARS–CoV–2, influenza A, influenza B, and respiratory syncytial virus (RSV); the service is a molecular diagnostic assay performed by a laboratory analyst as the technical component and is typically provided in clinical laboratory or hospital laboratory settings for respiratory infection diagnosis and surveillance.
For related coverage guidance, see recent payer policy updates: B-Hemolytic Streptococcus Testing, Human Immunodeficiency Virus (HIV) — Coverage Criteria for Testing and Resistance Assays, Hepatitis Testing (A, B, C, D) Coverage Criteria.
Customize your policy alerts
Sign up for cpt 87637 policy alerts
Get alerted when payer policies referencing 87637 are released or updated.
Monitor payer policy activity